Published in Int J Pharm on November 21, 2005
Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater (2009) 11.95
Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm (2008) 7.67
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A (2006) 6.90
Physical approaches to biomaterial design. Nat Mater (2009) 4.01
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev (2012) 3.34
Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond) (2011) 3.33
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm (2008) 2.94
microPET-based biodistribution of quantum dots in living mice. J Nucl Med (2007) 2.76
Targeted drug delivery to tumors: myths, reality and possibility. J Control Release (2011) 2.69
Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small (2009) 2.59
Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics (2012) 2.35
Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res (2009) 2.32
Role of particle size in phagocytosis of polymeric microspheres. Pharm Res (2008) 2.23
Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. J Control Release (2007) 2.09
Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia. Nanotechnology (2009) 2.08
Toxicity of nanomaterials. Chem Soc Rev (2011) 2.07
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected]. Proc Natl Acad Sci U S A (2010) 2.05
Polymer particle shape independently influences binding and internalization by macrophages. J Control Release (2010) 2.05
Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim Biophys Acta (2009) 1.94
Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol (2012) 1.85
Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov (2011) 1.78
PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett (2012) 1.77
Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. J Control Release (2013) 1.77
Engineering nano- and microparticles to tune immunity. Adv Mater (2012) 1.75
Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release (2011) 1.72
Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials (2008) 1.70
Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm (2010) 1.67
Polymers for drug delivery systems. Annu Rev Chem Biomol Eng (2010) 1.66
Recognition, neutralization, and clearance of target peptides in the bloodstream of living mice by molecularly imprinted polymer nanoparticles: a plastic antibody. J Am Chem Soc (2010) 1.65
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release (2013) 1.64
The pursuit of a scalable nanofabrication platform for use in material and life science applications. Acc Chem Res (2008) 1.53
Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One (2011) 1.53
Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond) (2010) 1.51
Plasma clearance of bacteriophage Qbeta particles as a function of surface charge. J Am Chem Soc (2008) 1.41
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog Polym Sci (2007) 1.41
A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci (2012) 1.40
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol Pharm (2009) 1.38
Magnetic nanoparticles: surface effects and properties related to biomedicine applications. Int J Mol Sci (2013) 1.37
Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. J Clin Invest (2013) 1.36
Silver nanoplate contrast agents for in vivo molecular photoacoustic imaging. ACS Nano (2012) 1.34
Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles. PLoS One (2009) 1.31
PRINT: a novel platform toward shape and size specific nanoparticle theranostics. Acc Chem Res (2011) 1.30
Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes. Theranostics (2012) 1.30
Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging. Biomacromolecules (2007) 1.28
Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine (Lond) (2010) 1.28
Nanoparticles in modern medicine: state of the art and future challenges. Int J Nanomedicine (2007) 1.28
Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int J Nanomedicine (2007) 1.27
Macrophages recognize size and shape of their targets. PLoS One (2010) 1.26
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine (2011) 1.26
Multi-stage delivery nano-particle systems for therapeutic applications. Biochim Biophys Acta (2010) 1.23
DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination. Nat Nanotechnol (2014) 1.23
Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv (2012) 1.22
Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles. Biomaterials (2011) 1.20
Action and reaction: the biological response to siRNA and its delivery vehicles. Mol Ther (2012) 1.18
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug Deliv Rev (2012) 1.18
Targeted Nanodelivery of Drugs and Diagnostics. Nano Today (2010) 1.18
Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles. Pharmacol Rev (2012) 1.15
The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo. Proc Natl Acad Sci U S A (2011) 1.13
Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid). Pharm Res (2010) 1.13
Monofunctional and higher-valent platinum anticancer agents. Inorg Chem (2013) 1.13
Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. ACS Nano (2011) 1.13
Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies. Int J Nanomedicine (2010) 1.11
Multimodality Imaging of Integrin α(v)β(3) Expression. Theranostics (2011) 1.10
Nanovehicular intracellular delivery systems. J Pharm Sci (2008) 1.10
Nanoparticulate cellular patches for cell-mediated tumoritropic delivery. ACS Nano (2010) 1.09
Targeting angiogenesis using a C-type atrial natriuretic factor-conjugated nanoprobe and PET. J Nucl Med (2011) 1.09
New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface (2013) 1.09
The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. J Nanobiotechnology (2010) 1.08
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev (2015) 1.08
Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release (2014) 1.08
Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (Lond) (2014) 1.07
Small-molecule delivery by nanoparticles for anticancer therapy. Trends Mol Med (2010) 1.07
Peroxidase-mediated biodegradation of carbon nanotubes in vitro and in vivo. Adv Drug Deliv Rev (2013) 1.07
Combinatorial peptide libraries: mining for cell-binding peptides. Chem Rev (2013) 1.07
Needle-shaped polymeric particles induce transient disruption of cell membranes. J R Soc Interface (2010) 1.06
Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice. Virology (2013) 1.05
Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy. Nano Today (2012) 1.05
Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice. Nanomedicine (Lond) (2010) 1.04
Odyssey of a cancer nanoparticle: from injection site to site of action. Nano Today (2012) 1.04
Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation. J Control Release (2011) 1.03
Nanotechnology for delivery of drugs to the brain for epilepsy. Neurotherapeutics (2009) 1.03
Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications. Bioconjug Chem (2012) 1.02
Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat. Toxicol Appl Pharmacol (2010) 1.02
Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. ACS Nano (2010) 1.02
Boronate-mediated biologic delivery. J Am Chem Soc (2012) 1.02
Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA. Int J Pharm (2011) 1.01
Biodistribution of encapsulated indocyanine green in healthy mice. Mol Pharm (2009) 1.01
Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA. Br J Pharmacol (2009) 1.01
Zwitterionic chitosan derivatives for pH-sensitive stealth coating. Biomacromolecules (2010) 1.00
Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. Mol Pharm (2012) 1.00
Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity. Bioconjug Chem (2012) 1.00
Biologically optimized nanosized molecules and particles: more than just size. Bioconjug Chem (2011) 1.00
Stealth properties to improve therapeutic efficacy of drug nanocarriers. J Drug Deliv (2013) 0.99
Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. ACS Nano (2014) 0.99
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol (2011) 0.98
Canonical and non-canonical barriers facing antimiR cancer therapeutics. Curr Med Chem (2013) 0.98
Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Mol Pharm (2013) 0.97
Hydrogels in regenerative medicine. Adv Mater (2009) 3.80
Polymers for drug delivery systems. Annu Rev Chem Biomol Eng (2010) 1.66
Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev (2007) 1.57
25th anniversary article: Rational design and applications of hydrogels in regenerative medicine. Adv Mater (2014) 1.52
Is the oral route possible for peptide and protein drug delivery? Drug Discov Today (2006) 1.38
Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J Control Release (2004) 1.38
Molecular imprinting within hydrogels. Adv Drug Deliv Rev (2002) 1.36
Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers. Acc Chem Res (2011) 1.31
Higuchi equation: derivation, applications, use and misuse. Int J Pharm (2011) 1.29
Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures. Eur J Pharm Biopharm (2004) 1.24
Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels. Biomaterials (2006) 1.20
Bioinspired materials for controlling stem cell fate. Acc Chem Res (2010) 1.19
Targeted Nanodelivery of Drugs and Diagnostics. Nano Today (2010) 1.18
Nanocomposite hydrogels for biomedical applications. Biotechnol Bioeng (2013) 1.15
Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers. J Biomed Mater Res A (2003) 1.15
Building vascular networks. Sci Transl Med (2012) 1.14
Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery. Biomacromolecules (2008) 1.12
Modeling of drug release from biodegradable polymer blends. Eur J Pharm Biopharm (2008) 1.12
Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J Control Release (2004) 1.12
Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates. Biomaterials (2006) 1.12
Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems. Adv Drug Deliv Rev (2009) 1.10
Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats. J Control Release (2005) 1.10
Critical review and perspective of macromolecularly imprinted polymers. Acta Biomater (2011) 1.09
Design of poly(ethylene glycol)-tethered copolymers as novel mucoadhesive drug delivery systems. Eur J Pharm Biopharm (2005) 1.08
Physicochemical behavior and cytotoxic effects of p(methacrylic acid-g-ethylene glycol) nanospheres for oral delivery of proteins. J Control Release (2002) 1.08
Floating hot-melt extruded tablets for gastroretentive controlled drug release system. J Control Release (2006) 1.06
Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J Control Release (2002) 1.06
pH-Sensitive hydrogels as gastrointestinal tract absorption enhancers: transport mechanisms of salmon calcitonin and other model molecules using the Caco-2 cell model. Biotechnol Prog (2002) 1.06
Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum. Int J Pharm (2006) 1.05
Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids. J Control Release (2006) 1.02
Development of acrylic-based copolymers for oral insulin delivery. Eur J Pharm Biopharm (2004) 1.02
Oral chemotherapeutic delivery: design and cellular response. Ann Biomed Eng (2005) 1.02
Cellular evaluation of oral chemotherapy carriers. J Biomed Mater Res A (2005) 1.01
Network structure of cellulose ethers used in pharmaceutical applications during swelling and at equilibrium. Pharm Res (2002) 1.01
Complexation hydrogels for intestinal delivery of interferon beta and calcitonin. J Control Release (2008) 1.01
Temperature-responsive polymer-gold nanocomposites as intelligent therapeutic systems. J Biomed Mater Res A (2007) 0.98
Principles of transmucosal delivery of therapeutic agents. Biomed Pharmacother (2004) 0.98
Polybasic Nanomatrices Prepared By UV-initiated Photopolymerization. Macromolecules (2009) 0.97
Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. Eur J Pharm Biopharm (2008) 0.97
Microfabricated drug delivery devices. Int J Pharm (2005) 0.96
Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats. J Pharm Sci (2006) 0.96
Expert opinion: Responsive polymer nanoparticles in cancer therapy. Eur J Pharm Biopharm (2011) 0.96
Dynamics of Poly(ethylene glycol)-Tethered, pH Responsive Networks. Polymer (Guildf) (2007) 0.95
Synthesis and characterization of pH-sensitive glycopolymers for oral drug delivery systems. J Biomater Sci Polym Ed (2002) 0.94
Effect of poly (ethylene glycol) molecular weight and microparticle size on oral insulin delivery from P(MAA-g-EG) microparticles. Drug Dev Ind Pharm (2004) 0.94
In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers. Int J Pharm (2003) 0.92
The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models. Acta Biomater (2009) 0.92
The future of open- and closed-loop insulin delivery systems. J Pharm Pharmacol (2008) 0.92
Oral delivery of small RNA and DNA. J Control Release (2012) 0.92
Cellular evaluation of insulin transmucosal delivery. J Biomater Sci Polym Ed (2004) 0.92
Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion. Int J Pharm (2007) 0.92
Modeling of drug release from bulk-degrading polymers. Int J Pharm (2010) 0.91
Complexation Hydrogels for the Oral Delivery of Growth Hormone and Salmon Calcitonin. Ind Eng Chem Res (2010) 0.91
Advanced molecular design of biopolymers for transmucosal and intracellular delivery of chemotherapeutic agents and biological therapeutics. J Control Release (2011) 0.91
Recent advances in drug eluting stents. Int J Pharm (2012) 0.91
Hydrophilic molecularly imprinted poly(hydroxyethyl-methacrylate) polymers. J Biomed Mater Res A (2006) 0.90
Characterization of pH-responsive hydrogels of poly(itaconic acid-g-ethylene glycol) prepared by UV-initiated free radical polymerization as biomaterials for oral delivery of bioactive agents. J Biomed Mater Res A (2010) 0.90
Applications of biomimetic systems in drug delivery. Expert Opin Drug Deliv (2005) 0.89
Advances in recognitive, conductive and responsive delivery systems. J Control Release (2008) 0.89
Assessment of poly(methacrylic acid-co-N-vinyl pyrrolidone) as a carrier for the oral delivery of therapeutic proteins using Caco-2 and HT29-MTX cell lines. J Biomed Mater Res A (2010) 0.88
Enhanced core hydrophobicity, functionalization and cell penetration of polybasic nanomatrices. Pharm Res (2008) 0.88
pH-Responsive Hydrogels with Dispersed Hydrophobic Nanoparticles for the Delivery of Hydrophobic Therapeutic Agents. Polym Int (2012) 0.86
Molecular structure of physiologically-responsive hydrogels controls diffusive behavior. Macromol Biosci (2009) 0.86
Preparation of stable insulin-loaded nanospheres of poly(ethylene glycol) macromers and N-isopropyl acrylamide. J Control Release (2002) 0.86
A novel model and experimental analysis of hydrophilic and hydrophobic agent release from biodegradable polymers. J Biomed Mater Res A (2009) 0.85
Designing biomaterials to direct stem cell fate. ACS Nano (2012) 0.85
Therapeutic applications of hydrogels in oral drug delivery. Expert Opin Drug Deliv (2014) 0.84
Synthesis and characterization of insulin-transferrin conjugates. Bioconjug Chem (2006) 0.84
Cellular evaluation of synthesized insulin/transferrin bioconjugates for oral insulin delivery using intelligent complexation hydrogels. Macromol Biosci (2010) 0.83
Cationic Nanogels Based On Diethylaminoethyl Methacrylate. Polymer (Guildf) (2010) 0.83
Microfabrication technologies for oral drug delivery. Adv Drug Deliv Rev (2011) 0.82
Hydrogels and scaffolds for immunomodulation. Adv Mater (2014) 0.82
Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration. J Control Release (2006) 0.82
Amphiphilic Interpenetrating Networks for the Delivery of Hydrophobic, Low Molecular Weight Therapeutic Agents. Ind Eng Chem Res (2011) 0.82
Recognitive biomimetic networks with moiety imprinting for intelligent drug delivery. J Biomed Mater Res A (2008) 0.82
pH-responsive hydrogels with dispersed hydrophobic nanoparticles for the oral delivery of chemotherapeutics. J Biomed Mater Res A (2012) 0.81
Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer. Int J Pharm (2007) 0.81
Polycationic nanoparticles for siRNA delivery: comparing ARGET ATRP and UV-initiated formulations. ACS Nano (2014) 0.80
Enzymatic biodegradation of hydrogels for protein delivery targeted to the small intestine. Biomacromolecules (2015) 0.80
Responsive and recognitive hydrogels using star polymers. J Biomed Mater Res A (2004) 0.80
Protein conformational studies for macromolecularly imprinted polymers. Macromol Biosci (2012) 0.80
Analyzing polyaniline-poly(2-acrylamido-2-methylpropane sulfonic acid) biocompatibility with 3T3 fibroblasts. J Biomater Sci Polym Ed (2010) 0.80
Alginate films as macromolecular imprinted matrices. J Biomater Sci Polym Ed (2010) 0.80
Micro- and nanoengineering of biomaterials for healthcare applications. Adv Healthc Mater (2013) 0.79
Surface imprinted thin polymer film systems with selective recognition for bovine serum albumin. Anal Chim Acta (2012) 0.79
In honor of Takeru Higuchi. Int J Pharm (2011) 0.78
Quantifying Tight Junction Disruption Caused by Biomimetic pH-Sensitive Hydrogel Drug Carriers. J Drug Deliv Sci Technol (2008) 0.78
Microcantilever sensing arrays from biodegradable, pH-responsive hydrogels. Biomed Microdevices (2011) 0.78
Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation. Biomacromolecules (2014) 0.78
Versatile Route to Colloidal Stability and Surface Functionalization of Hydrophobic Nanomaterials. Langmuir (2016) 0.78
Theranostic agents for intracellular gene delivery with spatiotemporal imaging. Nano Today (2013) 0.77
In Vivo Simulations of the Intravenous Dynamics of Submicron Particles of pH-Responsive Cationic Hydrogels in Diabetic Patients. Ind Eng Chem Res (2008) 0.77
Assemblage of novel release modules for the development of adaptable drug delivery systems. J Control Release (2006) 0.77
pH-responsive hydrogels containing PMMA nanoparticles: an analysis of controlled release of a chemotherapeutic conjugate and transport properties. J Biomater Sci Polym Ed (2012) 0.77
Advances in oral drug delivery: improved bioavailability of poorly absorbed drugs by tissue and cellular optimization. Preface. Adv Drug Deliv Rev (2012) 0.76
Development of a protein sensing device utilizing interactions between polyaniline and a polymer acid dopant. Biomed Microdevices (2010) 0.76
Conformational studies of common protein templates in macromolecularly imprinted polymers. Biomed Microdevices (2012) 0.76
Parameter set uniqueness and confidence limits in model identification of insulin transport models from simulation data. Diabetes Technol Ther (2008) 0.75
Polymeric nanocarriers for siRNA delivery to murine macrophages. Macromol Biosci (2014) 0.75